An AllTrials project

NCT06118281: An ongoing trial by Novo Nordisk A/S

This trial is ongoing. It must report results 1 year, 8 months from now.

Full data

Full entry on ClinicalTrials.gov NCT06118281
Title ARTEMIS - Effects of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Patients With Acute Myocardial Infarction
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date June 25, 2024
Completion date Sept. 3, 2026
Required reporting date Sept. 3, 2027, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Dec. 12, 2025
Days late None